8-KRegulation FDOther EventsExhibits & Filings

CENTENE CORP 8-K Report, Regulation FD Disclosure (Dec 12, 2023)

Filed December 12, 2023For Securities:CNC

Summary

Centene Corporation (CNC) announced its 2024 financial guidance and reaffirmed its 2023 guidance for premium and service revenues, Health Benefits Ratio (HBR), and adjusted diluted earnings per share (EPS) in a press release dated December 12, 2023. The company also revealed that its Board of Directors has approved a significant $4.0 billion increase to its existing stock repurchase program, bringing the total available under the program to approximately $5.23 billion. These announcements were made in conjunction with Centene's investor day event, hosted by CEO Sarah London and other management team members, providing a platform for detailed discussion and outlook. Investors should pay close attention to the specific 2024 guidance metrics as they become available, as these will shape expectations for the company's performance in the upcoming fiscal year. The substantial increase in the stock repurchase authorization signals management's confidence in the company's financial position and its commitment to returning capital to shareholders. This event and the associated disclosures are critical for understanding Centene's strategic direction and financial trajectory.

Key Highlights

  • 1Centene Corporation (CNC) issued 2024 financial guidance, providing forward-looking expectations for the upcoming fiscal year.
  • 2The company reaffirmed its 2023 guidance for premium and service revenues, Health Benefits Ratio (HBR), and adjusted diluted earnings per share (EPS).
  • 3Centene's Board of Directors approved a $4.0 billion increase to the existing stock repurchase program.
  • 4The total availability under the stock repurchase program now stands at approximately $5.23 billion.
  • 5The announcements were made concurrently with Centene's investor day event.
  • 6CEO Sarah London and other management members hosted the investor day, which included a live webcast.

Frequently Asked Questions

The 2024 financial guidance provides investors with an outlook on Centene's expected financial performance, including revenue, profitability, and other key metrics for the upcoming year. This guidance is crucial for assessing the company's growth prospects and operational effectiveness.

The $4.0 billion increase in the stock repurchase program, bringing the total available to $5.23 billion, indicates that Centene's management is confident in the company's financial health and believes its stock is undervalued. This action demonstrates a commitment to returning capital to shareholders and can potentially boost the stock price by reducing the number of outstanding shares.

The press release dated December 12, 2023, which contains the announcements, is included as Exhibit 99.1 to this 8-K filing. The investor day event was also webcast live, and recordings or transcripts may be available on Centene's investor relations website (www.centene.com) under the Investors section.

No, Centene reaffirmed its previously issued guidance for 2023 concerning premium and service revenues, Health Benefits Ratio (HBR), and adjusted diluted earnings per share (EPS), indicating that the company expects to meet its current year targets.